Free Trial
ASX:SPL

Starpharma (SPL) Stock Price, News & Analysis

Starpharma logo

About Starpharma Stock (ASX:SPL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
351,391 shs
Average Volume
N/A
Market Capitalization
A$43.90 million
P/E Ratio
N/A
Dividend Yield
9.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SPL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter.

SPL Stock News Headlines

Starpharma’s DEP® SN38 Shows Promising Cancer Treatment Results
Starpharma Holdings: Advancing Clinical Pathways and Growth
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Starpharma Director Increases Shareholding Significantly
Syntara Limited (SNT.AX)
Starpharma Holdings Limited (SPHRF)
See More Headlines

SPL Stock Analysis - Frequently Asked Questions

Starpharma Holdings Limited (ASX:SPL) issued its earnings results on Wednesday, February, 27th. The company reported ($0.02) earnings per share for the quarter. Starpharma had a negative trailing twelve-month return on equity of 26.10% and a negative net margin of 91.45%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Starpharma investors own include Starpharma (SPHRY), Allena Pharmaceuticals (ALNA), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), AstraZeneca (AZN), Arbutus Biopharma (ABUS) and AcelRx Pharmaceuticals (ACRX).

Company Calendar

Last Earnings
2/27/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:SPL
CIK
N/A
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$8.16 million
Net Margins
-91.45%
Pretax Margin
N/A
Return on Equity
-26.10%
Return on Assets
-11.48%

Debt

Debt-to-Equity Ratio
12.55
Current Ratio
4.94
Quick Ratio
5.65

Sales & Book Value

Annual Sales
A$9.76 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
10.42
Book Value
A$0.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
417,370,000
Free Float
N/A
Market Cap
A$43.90 million
Optionable
Not Optionable
Beta
0.77
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:SPL) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners